Khat: An Overview for GPs

Al Motarreb A. Briancon S. Al Jaber N. Al-Adhi B. Al-Jailani F. Salek M.S. Broadley K.K. (2005). Khat chewing is a risk factor for acute myocardial infarction: A case-control study. British Journal of Clinical Pharmacology 59: 574–581. doi:10.1111/j.1365–2125.2005.02358.x.

Al Motarreb A. Broadley K.J. (2003). Coronary and aortic vasoconstriction by cathinone, the active constituent of khat. Autonomic and Autacoid Pharmacology 23: 319–326. doi:10.1111/j.1474–8673.2004.00303.x.

Ali A. Al-Sharabi A. Aguirre J. Nahas R. (2004). A study of 342 oral keratotic white lesions induced by qat chewing among 2500 Yemeni. Journal of Oral Pathology and Medicine 33: 368–372. doi:10.1111/j.1600–0714.2004.00145.x.

Anderson D. Beckerleg S. Hailu D. Klein A. (2007). The Khat Controversy: Stimulating the Debate on Drugs. Berg Publishers, London.

Anderson D. Carrier N. (2011). ‘Khat: Social Harms and Legislation. A Literature Review’ Home Office. Retrieved from: www.homeoffice.gov.uk/publications/science-research-statistics/research-statistics/crime-research/occ95?view=Binary.

BBC (2006). Harmless Habbit or Dangerous Drug. Retrieved from: www.news.bbc.co.uk/1/hi/uk/4615415.stm.

Burton R. (2004). First Footsteps in East Africa. Kessinger Publishing. First published 1856 Longman, Brown, Green, and Longmans.

Cox G. Rampes H. (2003). Adverse effects of khat: A review. Advances in Psychiatric Treatment 9: 456–463. doi:10.1192/apt.9.6.456.

Critchlow S. Seifert R. (1987). Khat-induced paranoid psychosis. British Journal of Psychiatry 150: 247–249. doi:10.1192/bjp.150.2.247.

Department of Health (England) and the devolved administrations (2007). Drug Misuse and Dependence: UK Guidelines on Clinical management. Retrieved from: www.nta.nhs.uk/uploads/clinical_guidelines_2007.pdf.

The Economist (2002). High and dry. Why Yemen Is Running Out of Water. Retrieved from: www.economist.com/node/1059166.

The Economist (2010). Yeman's Bad Habit. You Can't Easily Qat It Out. Retrieved from: www.economist.com/node/17155919.

El-Shoura S.M. Aziz Abdel M. Ali M.E. El-Said M.M. Ali K.Z.M. Kemeir M.A. Elmalik E.M.A. (1995). Deleterious effects of khat addiction on semen parameters and sperm ultrastructure. Human Reproduction,10: 2295–2300.

Eriksson M. Ghani N.A. Kristiansson B. (1991). Khat-chewing during pregnancy-effect upon the offspring and some characteristics of the chewers. East African Medical Journal 68: 106–111.

Gebissa E. (2004). Leaf of Allah. Ohio State University Press, Ohio.

Gough S. Cookson I. Mayberry J. Morgan G. Perkin E. (1984). Khat-induced schizophreniform psychosis in UK. Lancet 1 (8374): 455. doi:10.1016/S0140–6736(84)91789–6.

Havell C. (2004). K hat Use in Somali, Ethiopian and Yemeni Communities in England: Issues. Report by Turning point. Retrieved from: www.12steptreatmentcentres.com/Articles/khat%20report05.pdf.

Kalix P. (1990). Pharmacological properties of the stimulant khat. Pharmacology & Therapeutics 48 (3): 397–416. doi:10.1016/0163–7258(90)90057–9.

Kalix P. (1991). The pharmacology of psychoactive alkaloids from ephedra and Catha. Journal of Ethnopharmacology 32 (1–3): 201–208. doi:10.1016/0378–8741(91)90119-X.

Kristiansson B. Ghanib Abdul N. Eriksson M. Garled M. Qirbib A. (1987). Use of khat in lactating women: A pilot study on breast-milk secretion. Journal of Ethnopharmacology 21: 85–90. doi:10.1016/0378–8741(87)90097–3.

Nasr A.H. Khatri M. (2000). Head and neck squamous cell carcinoma in Hajjah, Yemen. Saudi Medical Journal 21 (6): 565–568. Retrieved from: www.smj.org.sa/PDFFiles/Jun00/HeadandNeck.pdf.

Nencini P. Ahmed A. (1989). Khat consumption: A pharmacological review. Drug and Alcohol Dependence 23: 19–29. doi:10.1016/0376–8716(89)90029-X.

Numan N. (2004). Exploration of adverse psychological symptoms in Yemeni khat users by the Symptoms Checklist-90 (SCL-90). Addiction 99: 61–65. doi:10.1111/j.1360–0443.2004.00570.x.

Odenwald M. Neuner F. Schauer M. Elbert T. Catani C. Ligenfelder B. Rockstroh B. (2005). Khat use as risk factor for psychotic disorders: A cross-sectional and case-control study in Somalia. BMC Medicine 12 (3): 5. doi:10.1186/1741–7015-3–5.

Pantelis C. Hindler C. Taylor J. (1989). Khat toxic reactions to this substance, its similarities to amphetamine, and the implications of treatment for such patients. Journal of Substance Abuse Treatment 6: 205–206.

Patel L. Wright S. Gammampila A. (2005). K hat Use Among Somalis in Four English Cities. Home Office Report. Retrieved from: www.library.npia.police.uk/docs/hordsolr/rdsolr4705.pdf.

Tonnes S.W. Harder S. Schramm M. Niess C. Kauert G.F. (2006). Pharmacokinetics of cathinone, cathine and norephedrine after the chewing of khat leaves. British Journal of Clinical Pharmacology 56: 125–130. doi:10.1046/j.1365–2125.2003.01834.x.

Tonnes S. Kauert G. (2004). Driving under the influence of khat — alkaloid concentrations and observations in forensic cases. Forensic Science International 140 (1): 85–90.

WHO (2006). W HO Expert Committee on Drug Dependence: Assessment of Khat. Retrieved from: www.whqlibdoc.who.int/trs/WHO_TRS_942_eng.pdf.

Widler P. Mathys K. Brenneisen R. Kalix P. Fisch H.U. (1994). Pharmacodynamics and pharmacokinetics of khat: A controlled study. Clinical Pharmacology & Therapeutics 55: 556–562.